Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers

计划入组 37 人 · 首次发布于 2021 年 3 月 17 日

Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers

计划入组 62 人 · 首次发布于 2015 年 7 月 1 日

Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs

计划入组 104 人 · 首次发布于 2019 年 4 月 1 日

Tuvusertib

ATR-120

ATR-04

Astron Corp Ltd

United States

Exelixis, Inc.

United States

Inhibikase Therapeutics

United States

Cancer Immunotherapy Strategies Repurposed for Autoimmune Disease Treatment Show Promise in Early Studies

AstraZeneca's LATIFY Phase III Trial of Ceralasertib Plus Imfinzi Fails to Meet Primary Endpoint in Advanced Lung Cancer

Aprea Therapeutics Reports Promising Early Clinical Data for DNA Damage Response Inhibitors